Fundraising Fox
/Companies
Sign in

Keylika

YC S22

San Francisco, US · Founded 2022 · 1 employees · 4 known investors

Find your way into Keylika

Sign up to see every warm intro you have to Keylika

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Keylika team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.

BiotechHealthtechMedical DevicesAI-powered Drug DiscoveryDrug DeliveryNanotechnologyTherapeuticsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S22)

Keylika was founded in 2022 by Buddha Chaudhuri, Frederik Ceyssens, Frederik Ceyssens, PhD, and Buddhadev P. Chaudhuri.

BCBuddha Chaudhuri
Buddha ChaudhuriCEO & Co-FounderBuddha Chaudhuri led technology development for a microneedle biosensor at a Series B medtech company and has spent 15 years developing healthcare technologies across research institutes and biotech firms. He holds a PhD in Drug Delivery Microsystems from KU Leuven/Imec and completed a postdoctoral fellowship at UCSF/UC Berkeley.
FCFrederik Ceyssens
Frederik CeyssensCo-founder · CTOFrederik Ceyssens holds a PhD and Masters in IC design along with a Bachelor's in Medicine, and has spent 15 years developing microtechnologies for life science applications before founding Keylika, a neurotech venture focused on vision restoration.
FC
Frederik Ceyssens, PhDCTO & Co-Founder
BPBuddhadev P. Chaudhuri
Buddhadev P. ChaudhuriCEO & Co-Founder

Investors · 4

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Fundament Syndicatereported

How we know: Y Combinator's founder network · Not right? Tell us

GoodFin Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

The YC application· Summer 2022 batch

▶ Demo Day video — watch on YC ↗

What they told YC

Describe what your company does in 50 characters or less.
The company develops metallodrugs aimed at unmet medical needs.

Summarized from the founders' answers on their Y Combinator profile.

Related companies · 4

NanograbNanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.
ConvexiaConvexia provides AI-powered drug discovery and evaluation software that scans global sources for overlooked drug assets and runs deep in silico simulations across 50+ models to assess binding, toxicity, pharmacokinetics, and immunogenicity. The platform combines AI agents with expert human review to accelerate drug asset evaluation for biotech companies, pharma firms, and venture investors.
Intact TherapeuticsIntact Therapeutics develops next-generation biopharmaceutical therapies for gastrointestinal diseases to address unmet clinical needs. The company is clinical-stage and focused on improving patient outcomes through innovative medicines.
Avro Life ScienceAvro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration. The company operates in the biotech sector, focusing on dermatological and systemic therapeutics.

Companies working in the same space as Keylika.

Legal entities · 1

corporate structure
Keylika, Inc.

In the news

Keylika: Redefining the Standard of Care for Iron Deficiencyycombinator.com · Jul 2022

Frequently asked questions

What does Keylika do?
Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.
Who founded Keylika?
Keylika was founded by Buddha Chaudhuri, Frederik Ceyssens, Frederik Ceyssens, PhD, Buddhadev P. Chaudhuri in 2022.
Who are Keylika's investors?
Keylika's investors include Gaingels, Y Combinator, Fundament Syndicate, GoodFin Ventures.
Where is Keylika headquartered?
Keylika is headquartered in San Francisco, US.